Quantification of Anastomostic Blood Flow With Fluorescence Imaging in Low Anterior Resection for Rectal Cancer

Launched by ODENSE UNIVERSITY HOSPITAL · Nov 17, 2022

Keywords

ClinConnect Summary

This clinical trial is studying a new way to measure blood flow in patients undergoing surgery for rectal cancer. The goal is to find out how much blood flow is necessary to help the surgical connection heal properly and reduce the risk of a serious problem called anastomotic leakage (AL). AL can lead to severe complications, affect the patient’s quality of life, and create additional costs for the healthcare system. By using a special fluorescent dye and computer software, the researchers hope to set clear guidelines for what constitutes sufficient blood flow during surgery, making it easier for surgeons to ensure a successful outcome.

To participate in this trial, individuals must be at least 18 years old and plan to have laparoscopic or robotic surgery for rectal cancer. They should not have any allergies to iodide, severe kidney disease, or be pregnant or breastfeeding. Participants can expect to receive careful monitoring during their surgery and will contribute to important research aimed at improving surgical outcomes and patient well-being after rectal cancer surgery. The trial is not yet recruiting, but it aims to provide valuable insights into the long-term effects of surgical leaks on patients' lives.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients, older than 18, undergoing laparoscopic or robotic surgery for rectal cancer, with or without combination with trans-anal approach.
• Exclusion Criteria:
• • Allergy of iodide. Terminal renal disease. Pregnancy. Lactation. Previous left side colon resection or major surgery on intraabdominal vessels.